In recent studies, ASCL1/NEUROD1/POU2F3 triple-negative SCLC were found to be associated with mesenchymal transition and immune-related gene expression, designated as the fourth (SCLC-I) subtype. This evidence concerns the gene NEUROD1 and small cell lung carcinoma.